Aimei Health Technology (NASDAQ:AFJK) Hits New 52-Week High – Time to Buy?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $117.48 and last traded at $112.7590, with a volume of 159318 shares. The stock had previously closed at $82.58.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Monday. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

The stock has a 50-day moving average price of $23.93 and a two-hundred day moving average price of $15.65. The stock has a market cap of $391.74 million, a PE ratio of 304.82 and a beta of -3.95.

Aimei Health Technology (NASDAQ:AFJK) last issued its quarterly earnings data on Tuesday, November 18th. The company reported $0.06 earnings per share (EPS) for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Berkley W R Corp increased its position in Aimei Health Technology by 5.9% during the third quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock valued at $5,101,000 after acquiring an additional 25,294 shares during the last quarter. Crossingbridge Advisors LLC bought a new position in Aimei Health Technology during the 2nd quarter valued at about $2,147,000. Quarry LP raised its position in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares during the period. Clear Street Group Inc. bought a new stake in Aimei Health Technology in the third quarter worth about $691,000. Finally, Clear Street LLC boosted its position in shares of Aimei Health Technology by 63.8% during the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock valued at $441,000 after buying an additional 15,399 shares during the period. Hedge funds and other institutional investors own 45.58% of the company’s stock.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.